SPDR SSgA多資產實際回報ETF RLY 深 滬
等待開盤 07-17 09:30:00 美东时间
29.38
+0.120
+0.41%
華盛通- 最 高29.40
- 今 開29.40
- 成交量 6.39万股
- 最 低 29.19
- 昨 收 29.26
- 總市值 5.03亿
- 52周最高 30.04
- 市盈率 靜 --
- 換手率 0.37%
- 52周最低 25.3794
- 委 比 0.00%
- 總股本 1713.00万
- 歷史最高 30.04
- 量 比 0.59
- 振 幅 0.72%
- 歷史最低 7.013
- 每 手 1
- 風險率 0.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多KalVista gets UK nod for Ekterly
KalVista Pharmaceuticals (NASDAQ:KALV) said that the UK health regulator has granted marketing authorization for Ekterly (sebetralstat), a plasma inhibitor, to treat hereditary angioedema attacks in p...
07-16 04:44
Washington Trust donates 1,600 personal hygiene items to Amenity Aid
Bank collected donations during free document shredding event for community WESTERLY, R.I., July 15, 2025 /PRNewswire/ -- Washington Trust recently collected and donated 1,667 personal hygie...
07-15 23:26
玫瑰岛北交所IPO，聚焦定制家居产品，净利润逐年下滑
格隆汇获悉，近日，广东玫瑰岛家居股份有限公司（简称“玫瑰岛”）提交了招股说明书申报稿，拟于北京证券交易所上市，保荐人为国投证券。 玫瑰岛注册地为广东省中山市，公...
07-15 11:29
VULCAN DECLARES QUARTERLY DIVIDEND ON COMMON STOCK
BIRMINGHAM, Ala., July 11, 2025 /PRNewswire/ -- The Board of Directors of Vulcan Materials Company (NYSE: VMC) today declared a quarterly cash dividend of $0.49 per share on its common stock...
07-12 04:30
KalVista Pharmaceuticals: EKTERLY Launch and Financial Update
KalVista Pharmaceuticals, Inc. ( ($KALV) ) has released its Q4 earnings. Here i...
07-11 11:53
KalVista Pharmaceuticals GAAP EPS of -$3.69
KalVista Pharmaceuticals press release (NASDAQ:KALV): FY GAAP EPS of -$3.69. $220.6M in cash, providing runway into 2027 More on KalVista Pharmaceuticals KalVista: FDA Approval Of EKTERLY As Oral On-D...
07-10 19:01
KalVista Pharmaceuticals Gains FDA Approval for EKTERLY®
KalVista Pharmaceuticals ( ($KALV) ) has shared an update. On July 7, 2025, Kal...
07-07 20:59
KalVista Wins FDA Nod for EKTERLY, A New Pill to Treat Sudden HAE Attacks
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel plasma kallikrein inhibitor, for the treatment of acute
07-07 18:32
SM ENERGY DECLARES QUARTERLY CASH DIVIDEND
DENVER, June 26, 2025 /PRNewswire/ -- SM Energy Company (NYSE: SM) today announces that its Board of Directors approved the quarterly cash dividend of $0.20 per share of common stock outstan...
06-27 04:15
MATSON INCREASES QUARTERLY DIVIDEND TO $0.36 PER SHARE
HONOLULU, June 26, 2025 /PRNewswire/ -- The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, has declared a third quarter dividend of $0.36 per common ...
06-27 04:10
